Literature DB >> 85486

Facilitated light microscopic cytochemical diagnosis of acute myelogenous leukemia.

J S Hanker, W W Ambrose, C J James, J Mandelkorn, P E Yates, S A Gall, E H Bossen, J W Fay, J Laszlo, J O Moore.   

Abstract

Hydroperoxidase-positive Phi bodies and rods are much more prominent and prevalent than rods visualized with a Romanovsky-type stain (Auer rods) in immature leukocytes of patients with active acute myelogenous leukemia (AML). They are readily observed with the light microscope in peripheral blood or marrow films of AML patients stained to show their peroxidatic activity. In many of these patients, Auer rods, which apparently constitute only a small subpopulation of the hydroperoxidase-positive Phi bodies and rods, were detected with difficulty, if at all. The hydroperoxidase-positive Phi bodies and rods were observed in 92% of 36 patients with active disease. They were never observed in leukocytes of patients with other hematopoietic disorders or of normal individuals. Thus, they facilitated the distinction of AML from acute lymphocytic leukemia and chronic granulocytic leukemia in blast crisis. They were absent in full clinical remission after chemotherapy and were greatly diminished in partial remission. They were present in disease relapse and reappeared in five patients who had been in full remission. These results suggest that these hydroperoxidase-positive enlarged particles are pathognomonic of AML and that monitoring them with the light microscope may aid in guiding its clinical management.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 85486

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

1.  The light microscopic demonstration of hydroperoxidase-positive Phi bodies and rods in leukocytes in acute myeloid leukemia.

Authors:  J S Hanker; J Laszlo; J O Moore
Journal:  Histochemistry       Date:  1978-12-13

2.  Improved method for immunoperoxidase detection of membrane antigens in frozen sections.

Authors:  M A Green; L Sviland; A J Malcolm; A D Pearson
Journal:  J Clin Pathol       Date:  1989-08       Impact factor: 3.411

3.  Increased sensitivity in peroxidase immunocytochemistry. A comparative study of a number of peroxidase visualization methods employing a model system.

Authors:  L Scopsi; L I Larsson
Journal:  Histochemistry       Date:  1986

4.  Medusa cells: the morphology and cytochemistry of common amoeboid variants of eosinophils.

Authors:  J S Hanker; R J Chandross; N F Weatherly; J Laszlo; J O Moore; R H Buckley; A Ottolenghi
Journal:  Histochem J       Date:  1980-11

5.  Unusual structure of human splenic sinusoids revealed by monoclonal antibodies.

Authors:  R Giorno
Journal:  Histochemistry       Date:  1984

6.  Medusa cells: cytostructure and cytochemistry of amoeboid eosinophils with pseudopod-like processes.

Authors:  J S Hanker; R J Chandross; J J Solic; N F Weatherly; J Laszlo; J O Moore; A Ottolenghi
Journal:  Histochem J       Date:  1981-11

7.  The efficient isolation of murine splenic dendritic cells and their cytochemical features.

Authors:  Amir Hassan Zarnani; Seyyed-Mohammad Moazzeni; Fazel Shokri; Mojdeh Salehnia; Pouneh Dokouhaki; Jaleh Shojaeian; Mahmood Jeddi-Tehrani
Journal:  Histochem Cell Biol       Date:  2006-04-11       Impact factor: 4.304

8.  Immunofluorescent demonstration of myeloperoxidase of phi bodies and rods in leukaemic leucocytes.

Authors:  J Mandelkorn; M S Silverman; J E Harrison; J S Hanker
Journal:  Histochem J       Date:  1980-07

9.  Use of monoclonal antibodies for analyzing the distribution of the intermediate filament protein vimentin in human non-Hodgkin's lymphomas.

Authors:  R Giorno; C G Sciotto
Journal:  Am J Pathol       Date:  1985-09       Impact factor: 4.307

10.  Value of monoclonal anti-myeloperoxidase (MPO7) for diagnosing acute leukaemia.

Authors:  J Storr; G Dolan; E Coustan-Smith; D Barnett; J T Reilly
Journal:  J Clin Pathol       Date:  1990-10       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.